Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Sat Nusapersada Tbk (PTSN) vs Organon Pharma Indonesia Tbk. (SCPI)

Sat Nusapersada TbkTrading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Sat Nusapersada Tbk dan Organon Pharma Indonesia Tbk.: Sat Nusapersada Tbk diperdagangkan di Rp372 (kapitalisasi pasar 1,58 T, volume 24 jam 27,88 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sat Nusapersada Tbk jauh lebih besar — sekitar 15,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

PTSNSCPI
Kapitalisasi Pasar
1,58 T104,4 M
Volume
27,88 jt
Lot
278,82 rb
Perputaran
9,98 M
Harga Rata-rata
357,92
Nilai Transaksi
9,98 M
Harga Ekuilibrium Indikatif
372
Volume Ekuilibrium Indikatif
19,71 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

PTSN
Lihat detail
SCPI
Lihat detail

Tentang Sat Nusapersada Tbk

Sat Nusapersada Tbk (the company) was established on Jun 1, 1990 based on Notaries Deed No. 5 and the deed of establishment was approved by the the Ministry of Justice dated Sept 18, 1991. The Company’s articles of association has been amended several times, most recently by notarial deed No. 14 of Fathiah Helmi, S.H., dated Aug 7, 2007, concerning public offering.

Selengkapnya di halaman PTSN

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI